Cited by 436Cardiovascular Function and Risk FactorsCardiomyopathy and Myosin StudiesGout, Hyperuricemia, Uric Acid

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy

Cappola, Thomas P., Kass, David A., Nelson, Gregory S., Berger, Ronald D., Rosas, Gisele O., Kobeissi, Zoulficar A., Marbán, Eduardo, Hare, Joshua M.·2001·Circulation

DOI 10.1161/hc4501.098928

Open this paper in CoChat — free account

Abstract

Background Dilated cardiomyopathy is characterized by an imbalance between left ventricular performance and myocardial energy consumption. Experimental models suggest that oxidative stress resulting from increased xanthine oxidase (XO) activity contributes to this imbalance. Accordingly, we hypothesized that XO inhibition with intracoronary allopurinol improves left ventricular efficiency in patients with idiopathic dilated cardiomyopathy. Methods and Results Patients (n=9; ejection fraction, 29±3%) were instrumented to assess myocardial oxygen consumption (MV̇ o 2 ), peak rate of rise of left ventricular pressure (dP/dt max ), stroke work (SW), and efficiency (dP/dt max /MV̇ o 2 and SW/MV̇ o 2 ) at baseline and after sequential infusions of intracoronary allopurinol (0.5, 1.0, and 1.5 mg/min, each for 15 minutes). Allopurinol caused a significant decrease in MV̇ o 2 (peak effect, −16±5%; P <0.01; n=9) with no parallel decrease in dP/dt max or SW and no change in ventricular load. The net result was a substantial improvement in myocardial efficiency (peak effects: dP/dt max /MV̇ o 2 , 22±9%, n=9; SW/MV̇ o 2 , 40±17%, n=6; both P <0.05). These effects were apparent despite concomitant treatment with standard heart failure therapy, including ACE inhibitors and β-blockers. XO and its parent enzyme xanthine dehydrogenase were more abundant in failing explanted human myocardium on immunoblot. Conclusions These findings indicate that XO activity may contribute to abnormal energy metabolism in human cardiomyopathy. By reversing the energetic inefficiency of the failing heart, pharmacological XO inhibition represents a potential novel therapeutic strategy for the treatment of human heart failure.

Integrity signals

Registry

Crossref · 10.1161/hc4501.098928

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.
Doucette, J. W., Corl, P. D., Payne, H. M., Flynn, A. E., Goto, M., Nassí, M., & Segal, J. (1992) · Circulation · doi:10.1161/01.cir.85.5.1899 · Cited by 1,017
Activation of the Cardiac Calcium Release Channel (Ryanodine Receptor) by Poly-S-Nitrosylation
Xu, L., Eu, J. P., Meissner, G., & Stamler, J. S. (1998) · Science · doi:10.1126/science.279.5348.234 · Cited by 991
Effective arterial elastance as index of arterial vascular load in humans.
Kelly, R. P., Ting, C.-T., Yang, T. M., Liu, C. P., Maughan, W. L., Chang, M.-S., & Kass, D. A. (1992) · Circulation · doi:10.1161/01.cir.86.2.513 · Cited by 832
Self-citation
Ventricular energetics
Suga, H. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.247 · Cited by 744
Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion
Enroth, C., Eger, B. T., Okamoto, K., Nishino, T., Nishino, T., & Pai, E. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10723 · Cited by 733
A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure
Cohn, J. N., Goldstein, S., Greenberg, B., Lorell, B. H., Bourge, R. C., Jaski, B. E., Gottlieb, S. O., McGrew, F. A., DeMets, D. L., & White, B. G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392503 · Cited by 612
Increased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada.
Keith, M. E., Geranmayegan, A., Sole, M. J., Kurian, R., Robinson, A., Omran, A., & Jeejeebhoy, K. N. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00101-6 · Cited by 560
Elevated Levels of 8-iso-Prostaglandin F2αin Pericardial Fluid of Patients With Heart Failure
Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J., & Tedgui, A. (1998) · Circulation · doi:10.1161/01.cir.97.16.1536 · Cited by 458
Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols.
Campbell, D. L., Stamler, J. S., & Strauss, H. C. (1996) · The Journal of general physiology · doi:10.1085/jgp.108.4.277 · Cited by 441

Flagged first, then by citations

Show all 31 references

Research works printed but not linked: 9

10.1161/circ.93.5.932 · DOI
10.1161/circ.97.16.1536 · DOI
10.1161/res.83.4.423 · DOI
10.1161/res.85.5.437 · DOI
10.1161/circ.103.5.750 · DOI
10.1161/circ.92.8.2198 · DOI
10.1161/circ.94.10.2497 · DOI
10.1161/circ.97.4.363 · DOI
10.1161/circ.103.6.826 · DOI

Sorted by citations

Items 101–200 of 436

Update in uric acid, hypertension, and cardiovascular diseases
Kuwabara, M., Kodama, T., Ae, R., Kanbay, M., Andrés-Hernando, A., Borghi, C., Hisatome, I., & Lanaspa, M. A. (2023) · Hypertension Research · doi:10.1038/s41440-023-01273-3 · Cited by 92
Xanthine oxidoreductase: A journey from purine metabolism to cardiovascular excitation-contraction coupling
Agarwal, A., Banerjee, A., & Banerjee, U. C. (2011) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2010.527823 · Cited by 91
Upregulation of Glucose-6-Phosphate Dehydrogenase and NAD(P)H Oxidase Activity Increases Oxidative Stress in Failing Human Heart
Gupte, R. S., Vijay, V., Marks, B., Levine, R. J., Sabbah, H. N., Wolin, M. S., Recchia, F. A., & Gupte, S. A. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.04.003 · Cited by 88
Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure
Mellin, V., Isabelle, M., Oudot, A., Vergely, C., Monteil, C., Meglio, B. D., Henry, J., Dautréaux, B., Rochette, L., Thuillez, C., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi305 · Cited by 90
Pharmacology and Clinical Drug Candidates in Redox Medicine
Dao, V. T.-V., Casas, A. I., Maghzal, G. J., Seredenina, T., Kaludercic, N., Robledinos-Anton, N., Di Lisa, F., Stocker, R., Ghezzi, P., Jaquet, V., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6430 · Cited by 88
Metabolic remodelling in human heart failure
Tuunanen, H., & Knuuti, J. M. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr052 · Cited by 88
Allopurinol and mortality in hyperuricaemic patients
Luk, A. J., Levin, G. P., Moore, E. E., Zhou, X., Kestenbaum, B. R., & Choi, H. K. (2009) · Lara D. Veeken · doi:10.1093/rheumatology/kep069 · Cited by 88
Cellular redox dysfunction in the development of cardiovascular diseases
Kanaan, G. N., & Harper, M. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.07.027 · Cited by 87
Uric acid and xanthine oxidase in heart failure — Emerging data and therapeutic implications
Doehner, W., Jankowska, E. A., Springer, J., Lainščak, M., & Anker, S. D. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.089 · Cited by 88
Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort
Chuang, S., Chen, J., Yeh, W., Wu, C., & Pan, W. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.06.055 · Cited by 86
Changes in Uric Acid Levels and Allopurinol Use in Chronic Heart Failure: Association With Improved Survival
Gotsman, I., Keren, A., Lotan, C., & Zwas, D. R. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.06.528 · Cited by 86
Xanthine Oxidase Inhibitor, Allopurinol, Prevented Oxidative Stress, Fibrosis, and Myocardial Damage in Isoproterenol Induced Aged Rats
Sagor, M. A. T., Tabassum, N., Potol, M. A., & Alam, M. A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/478039 · Cited by 86
Serum Level of Uric Acid, Partly Secreted From the Failing Heart, is a Prognostic Marker in Patients With Congestive Heart Failure
Sakai, H., Tsutamoto, T., Tsutsui, T., Tanaka, T., Ishikawa, C., & Horie, M. (2006) · Circulation Journal · doi:10.1253/circj.70.1006 · Cited by 85
Nitric Oxide/Reactive Oxygen Species Generation and Nitroso/Redox Imbalance in Heart Failure: From Molecular Mechanisms to Therapeutic Implications
Nediani, C., Raimondi, L., Borchi, E., & Cerbai, E. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3198 · Cited by 83
Energy deficiency in the failing heart: Linking increased reactive oxygen species and disruption of oxidative phosphorylation rate
Sheeran, F. L., & Pepe, S. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.03.008 · Cited by 85
Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy
Rajesh, M., Mukhopadhyay, P., Bátkai, S., Mukhopadhyay, B., Patel, V., Haskó, G., Szabó, C., Mabley, J. G., Liaudet, L., & Pacher, P. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00564.x · Cited by 84
Pressure Overload–Induced Myocardial Hypertrophy in Mice Does Not Require gp91 phox
Maytin, M., Siwik, D. A., 伊藤, 正., Xiao, L., Sawyer, D. B., Liao, R., & Colucci, W. S. (2004) · Circulation · doi:10.1161/01.cir.0000117229.60628.2f · Cited by 86
Xanthine Oxidase Inhibition With Febuxostat Attenuates Systolic Overload-Induced Left Ventricular Hypertrophy and Dysfunction in Mice
Xu, X. Y., Hu, X., Lu, Z., Zhang, P., Zhao, L., Wessale, J. L., Bache, R. J., & Chen, Y. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.06.006 · Cited by 81
Superoxide radical production by allopurinol and xanthine oxidase
Galbusera, C., Orth, P., Fedida, D., & Spector, T. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.008 · Cited by 80
Na+/H+exchanger-1 inhibitors decrease myocardial superoxide production via direct mitochondrial action
Garciarena, C. D., Caldiz, C. I., Correa, M. V., Schinella, G. R., Mosca, S. M., de Cingolani, G. E. C., Cingolani, H. E., & Ennis, I. L. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90616.2008 · Cited by 82
Right Ventricular Failure in Idiopathic Pulmonary Arterial Hypertension Is Associated With Inefficient Myocardial Oxygen Utilization
Wong, Y. Y., Ruiter, G., Lubberink, M., Raijmakers, P. G. H. M., Knaapen, P., Marcus, J. T., Boonstra, A., Lammertsma, A. A., Westerhof, N., van der Laarse, W. J., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.962381 · Cited by 79
Xanthine Oxidase Inhibitor Allopurinol Prevents Oxidative Stress‐Mediated Atrial Remodeling in Alloxan‐Induced Diabetes Mellitus Rabbits
Yang, Y., Zhao, J., Qiu, J., Li, J., Liang, X., Zhang, Z., Zhang, X., Fu, H., Korantzopoulos, P. G., Letsas, Κ. P., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008807 · Cited by 78
Allopurinol as a Cardiovascular Drug
Kelkar, A. A., Kuo, A., & Frishman, W. H. (2011) · Cardiology in Review · doi:10.1097/crd.0b013e318229a908 · Cited by 77
‘Ryanopathy’: causes and manifestations of RyR2 dysfunction in heart failure
Belevych, A. E., Radwański, P., Carnes, C. A., & Györke, S. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt024 · Cited by 74
Cardiac-Resynchronization Therapy for Heart Failure
Hare, J. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmed020028 · Cited by 72
Self-citation
The Role of Urate and Xanthine Oxidase Inhibitors in Cardiovascular Disease
Casella, G., & Struthers, A. D. (2008) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00029.x · Cited by 72
Age-related increase in xanthine oxidase activity in human plasma and rat tissues
Aranda, R., Domènech, E. B., Rus, A. D., Real, J. T., Sastre, J., Viña, J., & Pallardó, F. V. (2007) · Free Radical Research · doi:10.1080/10715760701481461 · Cited by 72
Nitric oxide signaling in the cardiovascular system: implications for heart failure
Saraiva, R. M., & Hare, J. M. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000221584.56372.dc · Cited by 73
Self-citation
Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure
Amado, L. C., SALIARIS, A. P., Raju, S., Lehrke, S., John, M. S., XIE, J., Stewart, G. C., Fitton, T. P., Minhas, K. M., & BRAWN, J. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.04.008 · Cited by 72
Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure
Jankowska, E. A., Ponikowska, B., Majda, J., Zymliński, R., Trzaska, M., Reczuch, K. W., Borodulin-Nadzieja, L., Banasiak, W., & Ponikowski, P. P. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.10.033 · Cited by 69
Activation of cGMP/Protein Kinase G Pathway in Postconditioned Myocardium Depends on Reduced Oxidative Stress and Preserved Endothelial Nitric Oxide Synthase Coupling
Inserte, J., Hernando, V., Vilardosa, Ú., Abad, E., Poncelas, M., & David Garcia-dorado, A. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.005975 · Cited by 68
Xanthine Oxidase Inhibition Prevents Atrial Fibrillation in a Canine Model of Atrial Pacing‐Induced left Ventricular Dysfunction
Sakabe, M., Fujiki, A., Sakamoto, T., Nakatani, Y., Mizumaki, K., & Inoue, H. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02356.x · Cited by 69
Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts
Naumova, A. V., Chacko, V. P., Ouwerkerk, R., Stull, L. B., Marbán, E., & Weiss, R. G. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00831.2005 · Cited by 68
Allopurinol Initiation and Change in Blood Pressure in Older Adults With Hypertension
Beattie, C. J., Fulton, R. L., Higgins, P., Padmanabhan, S., McCallum, L., Walters, M. R., Dominiczak, A. F., Touyz, R. M., & Dawson, J. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03953 · Cited by 67
Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil
D’Avola, D., Cuervas‐Mons, V., Martí, J. M., de Urbina, J. O., Lladó, L., Jiménez, C., Otero, E., Suarez, F., Rodrigo, J., Gómez‐Bravo, M. Á., et al. (2017) · Liver Transplantation · doi:10.1002/lt.24738 · Cited by 71
Mononuclear Phagocyte Xanthine Oxidoreductase Contributes to Cytokine-Induced Acute Lung Injury
Wright, R. M., Ginger, L. A., Kosila, N., Elkins, N. D., Essary, B., McManaman, J. L., & Repine, J. E. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0309oc · Cited by 65
Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?: Figure 1
Doehner, W., & Anker, S. D. (2005) · Heart · doi:10.1136/hrt.2004.057190 · Cited by 65
How Exercise May Amend Metabolic Disturbances in Diabetic Cardiomyopathy
Hafstad, A. D., Boardman, N., & Aasum, E. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6304 · Cited by 63
Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy
Baldus, S., Müllerleile, K., Chumley, P., Steven, D., Rudolph, V., Lund, G. K., Staude, H.-J., Stork, A., Köster, R., Kähler, J., et al. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.07.010 · Cited by 63
Serum Uric Acid, Influence of Sacubitril–Valsartan, and Cardiovascular Outcomes in Heart Failure with Preserved Ejection Fraction: PARAGON-HF
Selvaraj, S., Claggett, B. L., Pfeffer, M. A., Desai, A. S., Causland, F. R. M., McGrath, M. M., Anand, I. S., van Veldhuisen, D. J., Køber, L., Janssens, S. P., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1984 · Cited by 64
Role of Oxidative Stress in Thyroid Hormone-Induced Cardiomyocyte Hypertrophy and Associated Cardiac Dysfunction: An Undisclosed Story
Elnakish, M. T., Ahmed, A. A. E., Mohler, P. J., & Janssen, P. M. L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/854265 · Cited by 63
Prognostic value of mechanical efficiency in ambulatory patients with idiopathic dilated cardiomyopathy in sinus rhythm
Kim, I. L. S., Izawa, H., Sobue, T., Ishihara, H., Somura, F., Nishizawa, T., Nagata, K., Iwase, M., & Yokota, M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01775-8 · Cited by 61
Free radicals in blood: Evolving concepts in the mechanism of ischemic heart disease
Elahi, M. M., & Matata, B. M. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.03.011 · Cited by 61
Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction
Shinke, T., Shite, J., Takaoka, H., Hata, K., Inoue, N., Yoshikawa, R., Matsumoto, H., Masai, H., Watanabe, S., Ozawa, T., et al. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.005 · Cited by 59
Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction
Shimizu, T., Yoshihisa, A., Kanno, Y., Takiguchi, M., Sato, A., Miura, S., Nakamura, Y., Yamauchi, H., Owada, T., Abe, S., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00533.2015 · Cited by 61
The Increase in Serum Uric Acid Concentration Caused by Diuretics Might be Beneficial in Heart Failure
Reyes, A. J. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.03.020 · Cited by 59
Redox signaling in heart failure and therapeutic implications
Weissman, D., & Maack, C. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.013 · Cited by 60
High Uric Acid Inhibits Cardiomyocyte Viability Through the ERK/P38 Pathway via Oxidative Stress
Li, Z., Shen, Y., Chen, Y., Zhang, G., Cheng, J., & Wang, W. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487356 · Cited by 57
Retracted
Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure
Freudenberger, R. S., Schwarz, R. P., Jr., Brown, J., Moore, A., Mann, D. L., Givertz, M. M., Colucci, W. S., & Hare, J. M. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.11.1509 · Cited by 58
Self-citation
Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves
Silva, R. A. P., Miller, J. D., Chu, Y., & Heistad, D. D. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00570.2009 · Cited by 56
The Role of Uric Acid in Acute and Chronic Coronary Syndromes
Maloberti, A., Biolcati, M., Ruzzenenti, G., Giani, V., Leidi, F., Monticelli, M., Algeri, M., Scarpellini, S., Nava, S., Soriano, F. S., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204750 · Cited by 55
Hyperuricemia: a novel old disorder—relationship and potential mechanisms in heart failure
Borghi, C., Palazzuoli, A., Landolfo, M., & Cosentino, E. R. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09869-z · Cited by 57
Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy
Duncan, J. G., Ravi, R., Stull, L. B., & Murphy, A. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00168.2005 · Cited by 55
Novel insights into interactions between mitochondria and xanthine oxidase in acute cardiac volume overload
Gladden, J. D., Zelickson, B. R., Wei, C.-C., Ulasova, E., Zheng, J., Ahmed, M. I., Chen, Y., Bamman, M., Ballinger, S., Darley-Usmar, V., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.022 · Cited by 54
Uric acid lowering therapy in cardiovascular diseases
Volterrani, M., Iellamo, F., Sposato, B., & Romeo, F. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.088 · Cited by 53
Uric Acid, Heart Failure Survival, and the Impact of Xanthine Oxidase Inhibition
Harzand, A., Tamariz, L. J., & Hare, J. M. (2011) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2011.00262.x · Cited by 53
Self-citation
Maternal Allopurinol Prevents Cardiac Dysfunction in Adult Male Offspring Programmed by Chronic Hypoxia During Pregnancy
Niu, Y., Kane, A. D., Lusby, C., Allison, B. J., Chua, Y. Y., Kaandorp, J. J., Nevin-Dolan, R., Ashmore, T. J., Blackmore, H. L., Derks, J. B., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11363 · Cited by 50
Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium
Kögler, H. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00512-1 · Cited by 53
Uric acid in heart failure: a biomarker or therapeutic target?
Kaufman, M., & Guglin, M. E. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9322-2 · Cited by 52
Reactive Oxygen Species/Nitric Oxide Mediated Inter-Organ Communication in Skeletal Muscle Wasting Diseases
Leitner, L. M., Wilson, R. J., Yan, Z., & Gödecke, A. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6942 · Cited by 54
Hyperuricemia, A new cardiovascular risk
Kuwabara, M., Hisatome, I., Ae, R., Kosami, K., Aoki, Y., Andrés-Hernando, A., Kanbay, M., & Lanaspa, M. A. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.103796 · Cited by 49
Hyperuricemia in acute heart failure. More than a simple spectator?
Alimonda, A. L., Núñez, J. E., Núñez, E., Hüsser, O., Sanchís, J. M., Bodı́, V., Miñana, G., Robles, R., Mainar, L., Merlos, P., et al. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.04.007 · Cited by 49
Increased levels of uric acid predict haemodynamic compromise in patients with heart failure independently of B-type natriuretic peptide levels: Figure 1
Kittleson, M. M., John, M. E. S., Bead, V. R., Champion, H. C., Kasper, E. K., Russell, S. D., Wittstein, I. S., & Hare, J. M. (2007) · Heart · doi:10.1136/hrt.2006.090845 · Cited by 49
Self-citation
The Potential for Xanthine Oxidase Inhibition in the Prevention and Treatment of Cardiovascular and Cerebrovascular Disease
Higgins, P., Dawson, J., & Walters, J. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/282059 · Cited by 49
Biochemical and Mechanical Dysfunction in a Mouse Model of Desmin-Related Myopathy
Maloyan, A., Osińska, H. E., Lammerding, J., Lee, R. T., Cingolani, O. H., Kass, D. A., Lorenz, J. N., & Robbins, J. M. (2009) · Circulation Research · doi:10.1161/circresaha.108.193516 · Cited by 51
Self-citation
Nitric oxide in blood
Elahi, M. M., Naseem, K. M., & Matata, B. M. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05660.x · Cited by 53
Xanthine oxidase and the fetal cardiovascular defence to hypoxia in late gestation ovine pregnancy
Kane, A. D., Hansell, J. A., Herrera, E. A., Allison, B. J., Niu, Y., Brain, K. L., Kaandorp, J. J., Derks, J. B., & Giussani, D. A. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.264275 · Cited by 48
Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration
Thompson, S., Martínez‐Burgo, B., Sepuru, K. M., Rajarathnam, K., Kirby, J. A., Sheerin, N., & Ali, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081692 · Cited by 49
Clinical Implications of Uric Acid in Heart Failure: A Comprehensive Review
Kumrić, M., Borovac, J. A., Kurir, T. T., & Božić, J. (2021) · Life · doi:10.3390/life11010053 · Cited by 49
Allopurinol, Xanthine Oxidase, and Cardiac Ischemia
Lee, B. E., Toledo, A. H., Anaya-Prado, R., Roach, R. R., & Toledo-Pereyra, L. H. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181bca50c · Cited by 46
Selective NADH communication from α-ketoglutarate dehydrogenase to mitochondrial transhydrogenase prevents reactive oxygen species formation under reducing conditions in the heart
Wagner, M., Bertero, E., Nickel, A. G., Kohlhaas, M., Gibson, G. E., Heggermont, W., Heymans, S. R. B., & Maack, C. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-0815-1 · Cited by 46
Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis‐related pulmonary arterial hypertension
Simpson, C. E., Damico, R. L., Hummers, L. K., Khair, R. M., Kolb, T. M., Hassoun, P. M., & Mathai, S. C. (2019) · Pulmonary Circulation · doi:10.1177/2045894019859477 · Cited by 45
Role of oxidative stress-related biomarkers in heart failure: galectin 3, α1-antitrypsin and LOX-1: new therapeutic perspective?
Lubrano, V., & Balzan, S. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03656-y · Cited by 45
Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin‐induced diabetes
Gao, X., Xu, Y., Xu, B., Liu, Y., Cai, J., Liu, H., Lei, S., Zhong, Y., Irwin, M. G., & Xia, Z. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2295 · Cited by 44
Biomarkers of Oxidative Stress in Heart Failure
Trachtenberg, B. H., & Hare, J. M. (2009) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.04.003 · Cited by 45
Self-citation
Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?
Duan, X., & Ling, F. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.06.018 · Cited by 44
Xanthine Oxidoreductase Inhibitors
Vickneson, K., & Casella, G. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_383 · Cited by 44
Role of Xanthine Oxidoreductase in the Reversal of Diastolic Heart Failure by Candesartan in the Salt-Sensitive Hypertensive Rat
Yamamoto, E., Kataoka, K., Yamashita, T., Tokutomi, Y., Dong, Y., Matsuba, S., Ogawa, H., & Kim‐Mitsuyama, S. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.095315 · Cited by 44
Allopurinol prevents cardiac and skeletal muscle damage in professional soccer players
Sanchis‐Gomar, F., Pareja-Galeano, H., Gómez‐Cabrera, M. C., Candel, J., Lippi, G., Salvagno, G. L., Mann, G. E., & Viña, J. (2014) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12213 · Cited by 44
Beyond gout: uric acid and cardiovascular diseases
Agabiti‐Rosei, E., & Grassi, G. M. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.790804 · Cited by 43
Effects of Allopurinol on Coronary Microvascular and Left Ventricular Function in Patients With Idiopathic Dilated Cardiomyopathy
Erdoğan, D., Tayyar, Ş., Uysal, B. A., İçli, A., Karabacak, M., Özaydın, M., & Doğan, A. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.04.005 · Cited by 43
Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg
Miranda‐Silva, D., Lima, T., Rodrigues, P., Leite-Moreira, A. F., & Falcão‐Pires, I. (2021) · Heart Failure Reviews · doi:10.1007/s10741-020-10042-0 · Cited by 45
Comparison between febuxostat and allopurinol uric acid-lowering therapy in patients with chronic heart failure and hyperuricemia: a multicenter randomized controlled trial
Suzuki, S., Yoshihisa, A., Yokokawa, T., Kobayashi, A., Yamaki, T., Kunii, H., Nakazato, K., Tsuda, A., Tsuda, T., Ishibashi, T., et al. (2021) · Journal of International Medical Research · doi:10.1177/03000605211062770 · Cited by 45
Hydralazine and Organic Nitrates Restore Impaired Excitation-Contraction Coupling by Reducing Calcium Leak Associated with Nitroso-Redox Imbalance*
Dulce, R. A., Yiğiner, Ö., González, D. R., Goss, G. M., Feng, N., Zheng, M., & Hare, J. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.412130 · Cited by 42
Self-citation
Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia
Chen, C.-C., Hsu, Y., & Lee, T. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01071.2010 · Cited by 41
Acute and Chronic Endothelial Dysfunction: Implications for the Development of Heart Failure
Linke, A., Recchia, F. A., Zhang, X., & Hintze, T. H. (2003) · Heart Failure Reviews · doi:10.1023/a:1022151106019 · Cited by 41
Role of Nitric Oxide in the Pathophysiology of Heart Failure
Champion, H. C., Skaf, M. W., & Hare, J. M. (2003) · Heart Failure Reviews · doi:10.1023/a:1022142904202 · Cited by 42
Self-citation
Chronic heart failure: an overview of conventional treatment versus novel approaches
Landmesser, U., & Drexler, H. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0371 · Cited by 39
Uric acid in chronic heart failure.
Doehner, W., & Anker, S. (2005) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.09.010 · Cited by 48
Xanthine Oxidase Inhibitors in Heart Failure: Where Do We Go From Here?
Tamariz, L., & Hare, J. M. (2015) · Circulation · doi:10.1161/circulationaha.115.016379 · Cited by 39
Self-citation
Effects of uric acid dysregulation on the kidney
Dissanayake, L. V., Spires, D. R., Palygin, O., & Staruschenko, A. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00066.2020 · Cited by 39
Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance
Nambu, H., Takada, S., Maekawa, S., Matsumoto, J., Kakutani, N., Furihata, T., Shirakawa, R., Katayama, T., Nakajima, T., Yamanashi, K., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa127 · Cited by 39
A 1 Adenosine Receptor Upregulation Accompanies Decreasing Myocardial Adenosine Levels in Mice With Left Ventricular Dysfunction
Funakoshi, H., Zacharia, L. C., Tang, Z., Zhang, J., Lee, L. L., Good, J. C., Herrmann, D. E., Higuchi, Y., Koch, W. J., Jackson, E. K., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.694596 · Cited by 39
Uric acid in heart disease: a new C-reactive protein?
Krishnan, E., & Sokolove, J. B. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283432dd3 · Cited by 39
Xanthine Oxidase Contributes to Mitochondrial ROS Generation in an Experimental Model of Cocaine-Induced Diastolic Dysfunction
Vergeade, A., Mulder, P. G. H., Vendeville, C., Ventura‐Clapier, R., Thuillez, C., & Monteil, C. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318271223c · Cited by 40
Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure
McCarty, M. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073321 · Cited by 41
Xanthine Oxido-Reductase, Free Radicals and Cardiovascular Disease. A Critical Review
Robert, A. M., & Robert, L. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9698-x · Cited by 37
An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome
Pagidipati, N. J., Hess, C. N., Clare, R. M., Åkerblom, A., Tricoci, P., WOJDYLA, D. M., Keenan, R. T., James, S. K., Held, C., Mahaffey, K. W., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.02.023 · Cited by 36
Serum Uric Acid Levels are Associated With Atrial Fibrillation in Patients With Ischemic Heart Failure
Tekin, G., Tekin, Y. K., Erbay, A. R., Turhan, H., & Yetkın, E. (2012) · Angiology · doi:10.1177/0003319712448247 · Cited by 36
Hyperuricemia and incident atrial fibrillation in a normotensive elderly population in Taiwan
Chuang, S., Wu, C., Hsu, P., Chen, R. C.-Y., Liu, W.-L., Hsu, Y.-Y., & Pan, W. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.03.012 · Cited by 35

Authors: Cappola, T. P., Kass, D. A., Nelson, G. S., Berger, R. D., Rosas, G. O., Kobeissi, Z. A., Marbán, E., & Hare, J. M.
Affiliations: Johns Hopkins University (US)
From the Department of Medicine, Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Md.
ORCID: Cappola, Thomas P.
Kass, David A.
Berger, Ronald D.
Hare, Joshua M.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2001-11-13
Volume: 104
Issue: 20
Pages: 2407-2411
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/hc4501.098928
OpenAlex: W2129194977
Cited by: 436
References: 31
Citations by year: 2026: 3 · 2025: 9 · 2024: 12 · 2023: 7 · 2022: 12 · 2021: 14 · 2020: 17 · 2019: 12 · 2018: 12 · 2017: 17 · 2016: 12 · 2015: 17 · 2014: 21 · 2013: 27 · 2012: 25
FWCI: 11.93
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: Johns Hopkins University
National Institutes of Health
National Heart, Lung, and Blood Institute (K08HL003238, K08-HL-03238, R01 HL65455, R01HL065455)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
Keywords: allopurinol, idiopathic dilated cardiomyopathy, xanthine oxidase inhibition, myocardial energy metabolism, myocardial oxygen consumption, stroke work, heart failure treatment, xanthine dehydrogenase, oxidative stress
MeSH terms: Allopurinol, Cardiomyopathy, Dilated, Enzyme Inhibitors, Female, Hemodynamics, Humans, Male, Middle Aged, Myocardial Contraction, Myocardium, Oxygen Consumption, Xanthine Oxidase, Oxidative Stress, Ventricular Dysfunction, Left

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks